01.12.2015 | Research article | Ausgabe 1/2015 Open Access

Clinical impact of high-attenuation and cystic areas on computed tomography in fibrotic idiopathic interstitial pneumonias
- Zeitschrift:
- BMC Pulmonary Medicine > Ausgabe 1/2015
Competing interests
Authors’ contributions
Background
Methods
Patients
Clinical evaluation
HRCT techniques
Quantitative CT analysis
-
l = CT value
-
n ( l) = number of pixels in each CT value
-
N = number of pixels in all CT values
-
SD = SD-LD
CT visual scoring
Statistical analyses
Results
Characteristics of study patients
Characteristics
|
Value
|
Range
|
---|---|---|
Demographics
|
||
Age, years
|
65.7 ± 9.2
|
(30 - 86)
|
Male
|
49 (66 %)
|
-
|
Smoking (yes)
|
45 (60 %)
|
|
Interval from diagnosis, months
|
58.1 ± 48.2
|
(1 - 263)
|
Diagnosis
|
||
IPF
|
36 (49 %)
|
|
NSIP
|
9 (12 %)
|
|
Other
|
29 (39 %)
|
|
Pulmonary function tests
|
||
%FVC, %
|
72.2 ± 20.0
|
(29.0 - 113.3)
|
%DLCO, %
|
54.1 ± 21.8
|
(10.3 - 122.9)
|
Quantitative CT indices
|
||
HAA% (>-200 HU), %
|
1.83 ± 1.15
|
(0.27 - 7.01)
|
LAA% (<-960 HU), %
|
3.91 ± 4.25
|
(0.14 - 22.5)
|
CA%, %
|
0.94 ± 1.85
|
(0 - 10.54)
|
MLD, HU
|
−758.0 ± 53.3
|
(−860.3 - −635.7)
|
SD-LD, HU
|
195.9 ± 22.6
|
(152.5 - 259.4)
|
Kurtosis
|
2.40 ± 1.81
|
(−0.53 - 7.45)
|
Skewness
|
1.61 ± 0.44
|
(0.66 -2.68)
|
CT visual scores
|
||
GGO score [0-5]
|
0.45 ± 0.52
|
(0 - 2.06)
|
Fibrosis score [0-5]
|
1.66 ± 0.68
|
(0.33 - 3.28)
|
Fibrosis score ≥2 in any field
|
48 (65 %)
|
Comparisons of quantitative CT indices, physiologic measures, and CT visual scores
HAA%
|
CA%
|
MLD
|
SD-LD
|
Kurtosis
|
Skewness
|
|
---|---|---|---|---|---|---|
%FVC
|
–0.59
|
–
|
−0.55
|
−0.52
|
0.48
|
0.49
|
%DLCO
|
−0.43
|
–
|
−0.56
|
−0.45
|
0.57
|
0.59
|
GGO
|
–
|
−0.40
|
–
|
–
|
–
|
–
|
Fibrosis
|
0.25
|
0.38
|
–
|
0.33
|
−0.28
|
−0.28
|
Comparison of quantitative CT indices in IPF and non-IPF groups
IPF (
n = 36)
|
Non-IPF (
n = 38)
|
P
|
|
---|---|---|---|
Pulmonary function tests
|
|||
%FVC, %
|
71.5 ± 20.7
|
72.9 ± 19.5
|
NS
|
%DLCO, %
|
56.0 ± 23.9
|
52.5 ± 19.9
|
NS
|
Quantitative CT indices
|
|||
HAA% (>-200 HU), %
|
1.90 ± 1.31
|
1.76 ± 0.99
|
NS
|
LAA% (<-960 HU), %
|
5.25 ± 5.17
|
2.64 ± 2.62
|
<0.01
|
CA%, %
|
1.50 ± 2.41
|
0.41 ± 0.80
|
<0.01
|
MLD, HU
|
−767.4 ± 51.0
|
−749.1 ± 54.6
|
NS
|
SD-LD, HU
|
197.6 ± 24.6
|
194.3 ± 20.7
|
NS
|
Kurtosis
|
2.54 ± 1.87
|
2.21 ± 1.82
|
NS
|
Skewness
|
1.67 ± 0.44
|
1.56 ± 0.45
|
NS
|
CT visual scores
|
|||
GGO score [0-5]
|
0.21 ± 0.25
|
0.67 ± 0.61
|
<0.01
|
Fibrosis score [0-5]
|
2.10 ± 0.44
|
1.23 ± 0.59
|
<0.01
|
Fibrosis score ≥2 in any field
|
35 (97 %)
|
13 (34 %)
|
<0.01
|
Definite UIP (
n = 35)
|
Other patterns (
n = 39)
|
P
|
|
---|---|---|---|
Pulmonary function tests
|
|||
%FVC, %
|
71.7 ± 20.6
|
73.0 ± 19.4
|
NS
|
%DLCO, %
|
54.8 ± 23.4
|
53.5 ± 20.6
|
NS
|
Quantitative CT indices
|
|||
HAA% (>-200 HU), %
|
1.93 ± 1.32
|
1.74 ± 0.98
|
NS
|
LAA% (<-960 HU), %
|
5.34 ± 5.22
|
2.63 ± 2.59
|
<0.01
|
CA%, %
|
1.54 ± 2.43
|
0.40 ± 0.79
|
<0.01
|
MLD, HU
|
−765.8 ± 50.9
|
−751.0 ± 55.2
|
NS
|
SD-LD, HU
|
198.2 ± 24.8
|
193.9 ± 20.6
|
NS
|
Kurtosis
|
2.50 ± 1.81
|
2.25 ± 1.82
|
NS
|
Skewness
|
1.66 ± 0.44
|
1.58 ± 0.45
|
NS
|
CT visual scores
|
|||
GGO score [0-5]
|
0.21 ± 0.25
|
0.66 ± 0.61
|
<0.01
|
Fibrosis score [0-5]
|
2.13 ± 0.41
|
1.23 ± 0.50
|
<0.01
|
Fibrosis score ≥2 in any field
|
35 (100 %)
|
13 (33 %)
|
<0.01
|
Prognostic value of quantitative CT analysis
Univariate
|
Multivariate
|
|||||
---|---|---|---|---|---|---|
HR
|
95 % CI
|
P
|
HR
|
95 % CI
|
P
|
|
Quantitative CT indices
|
||||||
HAA% (>-200 HU), %
|
1.47
|
(1.13 – 1.83)
|
< 0.01
|
1.06
|
(0.86 – 1.06)
|
NS
|
LAA% (<-960 HU), %
|
0.97
|
(0.86 – 1.06)
|
NS
|
|||
CA%, %
|
0.98
|
(0.75 – 1.16)
|
NS
|
|||
MLD, HU
|
1.01
|
(1.00 – 1.02)
|
0.01
|
|||
SD-LD, HU
|
1.03
|
(1.01 – 1.04)
|
< 0.01
|
|||
Kurtosis
|
0.67
|
(0.51 – 0.86)
|
< 0.01
|
0.67
|
(0.44 – 0.96)
|
0.03
|
Skewness
|
0.28
|
(0.11 – 0.65)
|
< 0.01
|
|||
CT visual scores
|
||||||
GGO score
|
0.74
|
(0.35 – 1.40)
|
NS
|
|||
Fibrosis score
|
2.00
|
(1.20 – 3.39)
|
0.01
|
1.06
|
(0.45 – 2.21)
|
NS
|
Definite UIP pattern
|
2.13
|
(1.05 – 4.47)
|
0.04
|
2.36
|
(0.84 – 7.60)
|
NS
|
Model 1
|
|||
---|---|---|---|
HR
|
95 % CI
|
P
|
|
Age
|
1.01
|
(0.97 – 1.06)
|
0.54
|
Kurtosis
|
0.67
|
(0.51 – 0.86)
|
<0.01
|
Model 2
|
|||
HR
|
95 % CI
|
P
|
|
Male
|
2.96
|
(1.23 – 8.78)
|
0.01
|
Kurtosis
|
0.66
|
(0.50 – 0.85)
|
<0.01
|
Model 3
|
|||
HR
|
95 % CI
|
P
|
|
IPF
|
2.85
|
(1.37 – 6.17)
|
<0.01
|
Kurtosis
|
0.62
|
(0.46 – 0.81)
|
<0.01
|
Model 4
|
|||
HR
|
95%CI
|
P
|
|
%FVC
|
0.98
|
(0.96 – 1.00)
|
0.05
|
Kurtosis
|
0.75
|
(0.55 – 0.97)
|
0.03
|
Model 5
|
|||
HR
|
95 % CI
|
P
|
|
%DLCO
|
0.96
|
(0.93 – 0.99)
|
0.01
|
Kurtosis
|
0.81
|
(0.57 – 1.07)
|
0.15
|